Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Results 1 - 10 of 28
Order by: Results/page:
12 3 > 
Combined Multi-marker Screening and Randomised Patient Treatment with Aspirin for Evidence-based Pre-eclampsia Prevention
ID: 601852
Start date: 2013-05-01, End date: 2016-10-31
"Project ASPRE is a commercially led development project that aims to boost translation of the results of PREGENESYS (FP6 EU #37244) into effective applications for prenatal care. PREGENESYS has identified several biomarkers for early (11-13 weeks’ gestation) and effective id...
Programme: FP7-HEALTH
Record Number: 108784
Last updated on: 2017-03-22
Genetic studies of pre-eclampsia in Central Asian and European populations
ID: 282540
Start date: 2011-11-01, End date: 2016-10-31
Pre-eclampsia, one of the most dangerous cardiometabolic complications of pregnancy, claims the lives of 50,000 mothers and almost one million babies annually. Pre-eclampsia and other hypertensive disorders of pregnancy remain the second most common cause of maternal death. T...
Programme: FP7-HEALTH
Record Number: 101106
Last updated on: 2017-03-22
Identifying best practices for care-dependent elderly by Benchmarking Costs and outcomes of community care
ID: 305912
Start date: 2013-01-01, End date: 2016-12-31
Problem: The need for cost effective health systems in Europe is imperative in the context of an increasing demand for health care by growing numbers of elderly people and a shrinking working force. Many health care systems are changing and looking for mechanisms to ensure, m...
Programme: FP7-HEALTH
Record Number: 106350
Last updated on: 2017-03-06
Neuropathic pain: biomarkers and druggable targets within the endogenous analgesia system
ID: 602891
Start date: 2014-01-01, End date: 2018-12-31
Neuropathic pain has a high incidence in Europe and often affects the patient’s emotional balance and quality of life. Recent meta-analyses have shown that conventional analgesic drugs are not sufficiently effective in these patients and are limited by serious side effects. T...
Programme: FP7-HEALTH
Record Number: 111184
Last updated on: 2016-12-26
Coordinating Action Systems Medicine – Implementation of Systems Medicine across Europe
ID: 305033
Start date: 2012-11-01, End date: 2017-04-30
The aim of CASyM is a combined large scale effort to sustainably implement Systems Medicine across Europe. For that purpose CASyM will function as a managing and coordinating platform in bringing together a critical mass of relevant European stakeholders such as Systems Biolo...
Programme: FP7-HEALTH
Record Number: 106187
Last updated on: 2016-12-05
Aggression subtyping for improved insight and treatment innovation in psychiatric disorders
ID: 602805
Start date: 2013-11-01, End date: 2018-10-31
Aggression is a basic physiological trait with important roles throughout evolution, both in defence and predation. When expressed in humans in the wrong context, aggression leads to maladjustment, social impairment and crime. Despite this, knowledge about aggression aetiolog...
Programme: FP7-HEALTH
Record Number: 110072
Last updated on: 2016-10-31
Development and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and non-drug Therapy in Older peRsons
ID: 305930
Start date: 2012-10-01, End date: 2017-09-30
The European population of older people with multiple chronic diseases (multimorbidity) is increasing steadily in tandem with the rising population of people aged ≥ 65 years. Older multimorbid people are at high risk of polypharmacy (PP), inappropriate prescribing (IP), adver...
Programme: FP7-HEALTH
Record Number: 105397
Last updated on: 2016-10-24
Advanced Immunization Technologies
ID: 280873
Start date: 2011-10-01, End date: 2017-09-30
Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious diseases we need to fully exploit the potential of the human immune system. Progress in science and technology makes it possible to ach...
Programme: FP7-HEALTH
Record Number: 100067
Last updated on: 2016-09-26
Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia
ID: 279227
Start date: 2011-11-01, End date: 2015-10-31
Treatment resistant schizophrenia (TRS) is the most disabling of all psychiatric illnesses, affecting about 1/3 of patients (~1 million Europeans), a considerable economic and social burden. First-line treatments include atypical (e.g. olanzapine) and typical (e.g. haloperido...
Programme: FP7-HEALTH
Record Number: 101231
Last updated on: 2016-09-12
TOWARDS SAFE AND EFFECTIVE IMMUNOTHERAPY OF PERSISTENT LIFE-THREATENING FOOD ALLERGIES
ID: 201871
Start date: 2008-09-01, End date: 2017-05-31
The FAST project aims at the development of safe and effective treatment of food allergies. It targets persistent and severe allergy to fish and fruit. Besides persistence and severity, this choice is based on prevalence and the importance of these foods for a healthy diet. C...
Programme: FP7-HEALTH
Record Number: 88227
Last updated on: 2016-09-12
12 3 > 
List retrieved on: 2017-04-27
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top